GLP-1 Dossier

Head to head

Hims vs Hers

Both are real, operating US telehealth companies. What separates them is what they supply, what they charge for it, and what regulators have published about each — all of it below, linked to the primary documents.

Hims
FDA-approved
$149/mo
Hers
FDA-approved
$149/mo
Hims on file
5
Hers on file
3

Side by side

What each one publishes about itself

Every figure here is the provider’s own advertised number, not an estimate. A dash means the company does not publish it.

HimsHers
SuppliesFDA-approved medication onlyFDA-approved medication only
Advertised from$149/mo$149/mo
First month$39$39
Medication in the priceBilled separatelyBilled separately
InsuranceCash payCash pay
IntakeAsyncAsync
On the record5 actions3 actions

The difference that actually matters

Supplies FDA-approved medication only — Wegovy, Zepbound, Ozempic, Mounjaro or the approved oral versions. Higher priced, and outside the compounding enforcement entirely.

On price: Hims advertises from $149 a month and Hers from $149. Compare what the two figures cover before comparing the figures: Hims bills medication separately, Hers bills it separately.

What is on Hims’s record

2025-09

FDA warning letter to Hims & Hers Health, Inc. dba Hims (MARCS-CMS 716567) over compounded GLP-1 marketing.

Primary source →

2025-06

Novo Nordisk terminated its collaboration with Hims & Hers, alleging illegal sham compounding and Chinese-sourced unapproved API.

Primary source →

2026-03

Novo Nordisk patent infringement suit filed February 2026 was dropped 9 March 2026 under a settlement in which Hims agreed to stop promoting compounded GLP-1s.

Primary source →

All 5 on the Hims page →

What is on Hers’s record

2025-09

FDA warning letter to Hims & Hers Health, Inc. dba Hers (MARCS-CMS 716825) over compounded GLP-1 marketing.

Primary source →

2026-07

FTC, State of Utah and Los Angeles County sued Hims & Hers, the same legal entity, over alleged health-data sharing and subscription billing practices; allegations unproven.

Primary source →

2026-03

Novo Nordisk patent suit dropped March 2026 under a settlement requiring Hims & Hers to move patients to FDA-approved products.

Primary source →

Go direct

Both companies, and what we earn from each

We do not recommend one over the other. Where a link pays us, it says so here and on the provider’s own page.

Hims

FDA-approved medication only, from $149 a month. 5 actions on record, each linked on its page. The link below earns us nothing.

Hers

FDA-approved medication only, from $149 a month. 3 actions on record, each linked on its page. The link below earns us nothing.

Straight answers

Hims vs Hers, in short

Is Hims or Hers cheaper?
Hims advertises the lower starting price — $149 a month against $149. Whether that is the cheaper purchase depends on what each figure covers: Hims bills medication separately, and Hers bills it separately.
What is the difference between Hims and Hers?
Both supply the same category of medication (fda-approved medication only), so the differences are price, how the consultation works, and what each one has on its regulatory record.
Which one has more regulatory actions on record?
Hims, with 5 sourced actions against 3 actions for Hers. Every one is linked to its primary document on the provider's own page. A larger file is not automatically a worse company — read what the documents actually say.

Other comparisons: Hims vs Ro (Ro Body) · Hims vs Henry Meds · Hims vs LillyDirect